banner add

C.D.C. Scales Back Recommendations for R.S.V. Vaccine

Fewer Americans age 60 to 74 should receive the shots, the agency concluded, citing reduced risks and a possible neurological side effect.

from NYT > Health https://ift.tt/FXUPuOT
via IFTTT

No comments

Melanoma Vaccine Ushers in New Hope for Cancer Patients

Beyond melanoma, scientists are studying cancer vaccines for glioblastoma, pancreatic cancer and more. from NYT > Health https://ift.tt...

Theme images by PLAINVIEW. Powered by Blogger.